Editas Medicine, Inc. (EDIT)
1.89
+0.10
(+5.59%)
USD |
NASDAQ |
Feb 23, 16:00
1.90
+0.01
(+0.53%)
Pre-Market: 09:00
Editas Medicine Price : 1.89 for Feb. 23, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 196.34 |
| ADMA Biologics, Inc. | 16.29 |
| Arcutis Biotherapeutics, Inc. | 26.31 |
| ACADIA Pharmaceuticals, Inc. | 24.73 |
| Alnylam Pharmaceuticals, Inc. | 329.35 |
Price Related Metrics
| PS Ratio | 3.465 |
| Price to Book Value | 13.71 |
| Earnings Yield | -125.8% |
| Market Cap | 184.50M |